Christopher Ross MacLeod

CIK: 0001765476

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ZOM

Zomedica Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ZOMDF
Zomedica Corp.
Nov 17, 2025
Award(A)
Stock Appreciation Right
Direct
1.8M shares-
ZOM
Zomedica Corp.
Mar 17, 2025
Purchase(P)
Direct
143K shares at avg. $0.06$8K
ZOM
Zomedica Corp.
Nov 11, 2024
Award(A)
Stock Appreciation Rights
Direct
1.8M shares-

		Type	Shares	Price		Ownership
Nov 17, 2025	ZOMDF Zomedica Corp.	Award(A) Stock Appreciation Right	1,823,107	-	-	Direct
Mar 17, 2025	ZOM Zomedica Corp.	Purchase(P)	143,000	$0.06	$8,437	Direct
Nov 11, 2024	ZOM Zomedica Corp.	Award(A) Stock Appreciation Rights	1,823,107	-	-	Direct

1-3 of 3 transactions

About MACLEOD CHRISTOPHER ROSS

MACLEOD CHRISTOPHER ROSS (SEC CIK 0001765476) files insider reports with the SEC as Director of Zomedica Corp. (ZOM).

Signal8 holds 3 ownership filings by MACLEOD CHRISTOPHER ROSS, all Form 4s, filed between Nov 13, 2024 and Nov 18, 2025. Those filings report 3 transactions, from Nov 11, 2024 to Nov 17, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on MACLEOD CHRISTOPHER ROSS's filings is in ANN ARBOR, MI.

Recent filings by MACLEOD CHRISTOPHER ROSS

Nov 17, 2025: Grant or award of ZOMDF derivative securities (Form 4, code A).
Mar 17, 2025: Open-market purchase of ZOM shares (Form 4, code P).
Nov 11, 2024: Grant or award of ZOM derivative securities (Form 4, code A).

Other insiders filing for Zomedica Corp. (ZOM)

POWERS JOHNNY D, Director
HEATON LARRY C II, CEO
Whelan Sean, Director
Nichols Pamela, Director
Cohen Robert, Director
Williams Rodney James, Director

How to read Form 4 transaction codes